Apellis Says Mixed Phase III Results Position Geographic Atrophy Candidate For Filing

 
• By Joseph Haas
  
Eye
Apellis hopes to get the first approval for a geographic atrophy drug
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D